15-06-2026 14:20 via wallstreet-online.de

AimwellBio Opens Verified Observer Network to Healthcare, Research, and Capital Professionals at No Cost

Aimwell Partners Inc. (OTCID:AIMN) expands Observer access, a credentialed professional intelligence network for biopharma, inviting doctors, scientists, regulatory professionals, and capital allocators to claim a verified profile and standing seat. …
Weiterlesen »